News

The FDA has approved trastuzumab-dttb (Ontruzant) for the treatment of patients with HER2-overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma in combination with cisplatin and capecitabine or 5-fluorouracil.

The FDA has approved Verily’s Study Watch, a wearable medical device that conducts electrocardiograms (ECGs).

Acrolein levels were significantly elevated in urine and serum in patients with multiple sclerosis compared to healthy controls.

Three newly discovered strains of HCV genotype 7 in Africa, and a genotype 8 in India, complicate the World Health Organization's goal to eradicate HCV.

Older age was associated with a lower likelihood of entering the ICU, but increased risk of death for hospitalized patients with influenza.

Why certain age-related factors particularly impact the mental health of women at the age their menopause symptoms appear.

The hypertension medication is again being recalled due to carcinogenic impurities.

The investigative SGLT1/2 dual inhibitor is scheduled to be considered for marketing approval by mid-March.

River blindness and elephantiasis are 2 of the leading causes of global disability.

University of Washington investigators found great disparities in AEMT-driven death rates among states and age groups.

Increased opioid prescribing correlated with marketing opioid products to physicians, which subsequently correlated with an increase in mortality from overdoses.

A four-year trial assessing the investigative vaccine in about 3000 pregnant women will announce efficacy results later this quarter.

As costs of treating COPD exacerbation continue to burden patients, investigators sought to determine a risk assessment tool that could lead to reduced costs.

Unlike assessments of pediatric patients, healthcare providers do not routinely include the family members or friends in the assessment of older adults—but they should.

Novel epidemiological approach accounting for persons with undiagnosed HCV shows half of cases in US are in 9 states, including 5 in Appalachia.

The FDA Bone, Reproductive, and Urologic Drugs Advisory Committee voted in favor of approving romosozumab for the treatment of postmenopausal women with osteoporosis at high risk for fracture.

Coronary artery disease remains the top killer of Americans—these tools may help identify people who are still at risk.

University of Pennsylvania investigators conducted an interim analysis of a year-long study on intraocular injections of a mutation-specific gene therapy when one patient showed dramatic early improvements.

A new review shows transgender women face higher HIV rates than transgender men, but also finds a relative lack of data about transmen.

Meta-analysis of other randomized controlled trials have shown that vitamin D supplementation reduces the risk of acute respiratory infections and exacerbations of asthma.

Ocrelizumab demonstrated superiority to or comparability with 14 other disease-modifying therapies currently approved by the European Medicines Agency.

The FDA has responded to the Janssen Pharmaceutical company's sNDA with a request for more data.

Improvements in muscle and cardiac function were observed for 18 months in tested mice.

This is the first generic approval of the tablet form of vigabatrin, which is indicated for treating focal seizures in patients with epilepsy.

The FDA has approved a scalpel-free method for the treatment of patients with Parkinson disease who experience tremors and are medication-resistant.

Currently in phase 1 testing, ACX-362E is being developed as a narrow spectrum antibiotic for the treatment of Clostridium difficile infection.

A noninvasive and age-specific test could facilitate surgery for focal epilepsy in children.

Success with metronidazole was more likely in patients 65 years and under but was about the same as with vancomycin in those patients.